Vet Loses DEA License: No More Controlled Critter Care
Published Date: 3/20/2025
Notice
Summary
Dr. Linwood A. Starks, a veterinarian from Texas, lost his DEA registration because he no longer has permission to handle controlled substances in Texas. Despite being given chances to respond, he didn’t defend himself, so the DEA officially revoked his registration. This means he can’t legally prescribe or handle certain drugs anymore, effective immediately, impacting his veterinary practice and any related business.
Analyzed Economic Effects
4 provisions identified: 1 benefits, 3 costs, 0 mixed.
DEA Registration Revoked for Dr. Starks
Dr. Linwood A. Starks, D.V.M.'s DEA Certificate of Registration No. FS5936919 is revoked effective April 21, 2025. That means he cannot legally prescribe, dispense, or handle controlled substances in connection with his veterinary practice.
Pending Registration Applications Denied
Any pending applications by Linwood A. Starks to renew or modify his DEA registration, and any other pending application for additional registration in Texas, are denied as of the order. This denial is part of the same order effective April 21, 2025.
State License Suspension Triggers DEA Revocation
Under 21 U.S.C. 824(a)(3) and related provisions, if a practitioner's state license is suspended or revoked and they are not authorized to handle controlled substances in that state, the DEA may revoke the practitioner's federal registration. The order cites the Texas suspension effective January 6, 2023 as the basis for revocation.
Right to File Reconsideration within 15 Days
The order states the registrant may file a properly supported motion for reconsideration of the findings of fact within fifteen calendar days of the date of the Order, filed and served by email to the DEA Office of the Administrator.
Your PRIA Score
Personalized for You
How does this regulation affect your finances?
Sign up for a PRIA Policy Scan to see your personalized alignment score for this federal register document and every other regulation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Related Federal Register Documents
2026-11526 — Implementation of the Substance Use-Disorder Prevention That Promotes Opioid Recovery and Treatment for Patients and Communities Act of 2018: Dispensing and Administering Controlled Substances for Medication-Assisted Treatment
Starting July 9, 2026, new rules make it easier for doctors and pharmacies to provide medicine that helps people recover from opioid addiction. These changes affect healthcare providers by expanding who can give medication-assisted treatment and how pharmacies can deliver these medicines. The goal? Faster, safer access to treatment with clear rules that save time and support recovery.
2026-10128 — Revision of Applications for Manufacturing and Procurement Quotas
The DEA wants to update how companies apply for permission to make and buy certain controlled drugs and chemicals. These changes will make the rules clearer, help prevent drug shortages, and ensure enough supply for medical and scientific needs. If you’re a manufacturer or involved in this process, get ready to follow new steps and share your thoughts by July 20, 2026.
2026-11909 — Importer of Controlled Substances Application: Cerilliant Corporation
Cerilliant Corporation wants to become an official importer of certain controlled substances, including some drugs that need strict government oversight. People and companies involved with these substances can share their thoughts or ask for a hearing by July 15, 2026. This move could affect how these drugs enter the U.S. and might impact businesses handling them.
2026-11572 — Ashley Vermillion, N.P.; Decision and Order
Ashley Vermillion, a nurse practitioner from Maine, lost her DEA registration because she no longer has the legal right to handle controlled substances in her state. She didn’t ask for a hearing, so the DEA moved forward and officially revoked her registration. This means she can’t prescribe or manage controlled drugs anymore, effective immediately.
2026-11416 — Importer of Controlled Substances Application: CalCog Inc.
CalCog Inc. wants to become an official importer of some powerful controlled substances like LSD and 5-MeO-DMT. People and companies involved with these drugs have until July 8, 2026, to share their thoughts or ask for a hearing. This move could shake up the import scene, but no costs or changes happen until the DEA decides.
2026-10380 — Schedules of Controlled Substances: Placement of Diphenidine in Schedule I
The DEA wants to put diphenidine, a drug, into Schedule I, which means it will be treated like the most tightly controlled substances. This change affects anyone who makes, sells, studies, or owns diphenidine, adding strict rules and penalties. You’ve got until June 25, 2026, to share your thoughts before the new rules might kick in.
Previous / Next Documents
Previous: 2025-04745 — Combined Notice of Filings #1
The Federal Energy Regulatory Commission got a bunch of new filings from energy companies about rates, refunds, and generator status. These changes could affect how some energy providers charge or report their costs, with some updates kicking in as soon as June 1, 2025. If you’re involved with these companies or follow energy prices, keep an eye on comment deadlines in early April—they’re your chance to speak up!
Next: 2025-04747 — National Register of Historic Places; Notification of Pending Nominations and Related Actions
The National Park Service wants your thoughts on historic places nominated before March 8, 2025, to be added to the National Register. If you care about preserving cool old buildings or sites, now’s your chance to speak up! This process helps protect history without costing you a dime, but don’t wait—comments close soon.